<DOC>
	<DOC>NCT00960882</DOC>
	<brief_summary>The purpose of this study is to determine the gastric tolerability and the pharmacokinetics of a new drug for the treatment of type 2 diabetes, DMMET-01, in healthy volunteers.</brief_summary>
	<brief_title>Gastric Tolerability and Pharmacokinetics of DMMET-01</brief_title>
	<detailed_description />
	<criteria>Mexican healthy subjects with normal clinical laboratory test results and imaging (hematology, blood chemistry, urine test, VDRL, Hepatitis B, HIV, chest radiography and electrocardiogram) Familiar or personal history of diabetes History of drug or alcohol abuse within the 2 years prior to the study A smoking habit greater tha 10 cigarettes per day Intercurrent disease Intercurrent treatment with any drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Diabetes</keyword>
	<keyword>gastric tolerability</keyword>
</DOC>